Glioblastoma
Glioblastoma is a fast-growing and aggressive type of brain cancer that arises from glial cells. It often requires surgery, radiation, and chemotherapy for treatment.
Glioblastoma: Radioimmunotherapy with Lutetium 177
We are investigating a new treatment using a targeted antibody for patients with glioblastoma. The study aims to determine the right dose and assess its safety and effectiveness.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Essen AöR
Klinik für Nuklearmedizin, Strahlenklinik
Essen, Germany
Universitaetsklinikum Essen AöR
Klinik für Neurochirurgie
Essen, Germany
University Hospital Cologne AöR
Zentrum für Neurochirurgie
Köln, Germany
Sponsor: Universitaetsklinikum Muenster AöR
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.